Protagonist Therapeutics Inc (PTGX)
41.49
+1.95
(+4.93%)
USD |
NASDAQ |
Dec 20, 16:00
41.51
+0.02
(+0.05%)
After-Hours: 20:00
Protagonist Therapeutics Market Cap: 2.473B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Assembly Biosciences Inc | 96.17M |
| Precision BioSciences Inc | 36.74M |
| Entrada Therapeutics Inc | 658.59M |
| NovaBay Pharmaceuticals Inc | 2.589M |
| Palatin Technologies Inc | 18.92M |
Market Cap Related Metrics
| PE Ratio | 15.60 |
| PS Ratio | 7.916 |
| Price to Book Value | 4.649 |
| Price to Free Cash Flow | 11.18 |
| Price | 41.49 |
| Earnings Yield | 6.41% |
| Operating PE Ratio | 17.19 |
| Normalized PE Ratio | 15.60 |